Bayforest Capital Ltd grew its position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 162.1% during the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 10,614 shares of the company's stock after purchasing an additional 6,565 shares during the quarter. Bayforest Capital Ltd's holdings in Doximity were worth $616,000 as of its most recent filing with the SEC.
Several other hedge funds also recently modified their holdings of the company. Vanguard Group Inc. increased its position in shares of Doximity by 4.5% during the 4th quarter. Vanguard Group Inc. now owns 11,203,569 shares of the company's stock valued at $598,159,000 after purchasing an additional 485,102 shares during the period. FMR LLC raised its position in shares of Doximity by 37.6% during the fourth quarter. FMR LLC now owns 9,409,313 shares of the company's stock worth $502,363,000 after purchasing an additional 2,571,580 shares during the period. Geode Capital Management LLC raised its position in shares of Doximity by 3.3% during the fourth quarter. Geode Capital Management LLC now owns 2,952,442 shares of the company's stock worth $157,668,000 after purchasing an additional 95,458 shares during the period. Renaissance Technologies LLC raised its position in shares of Doximity by 9.8% during the fourth quarter. Renaissance Technologies LLC now owns 1,847,702 shares of the company's stock worth $98,649,000 after purchasing an additional 164,200 shares during the period. Finally, Fuller & Thaler Asset Management Inc. raised its position in shares of Doximity by 8.5% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 1,579,708 shares of the company's stock worth $84,341,000 after purchasing an additional 124,216 shares during the period. 87.19% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at Doximity
In other news, Director Timothy S. Cabral sold 10,000 shares of the company's stock in a transaction dated Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total transaction of $600,000.00. Following the completion of the sale, the director owned 6,360 shares in the company, valued at approximately $381,600. This represents a 61.12% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Kira Scherer Wampler sold 2,000 shares of the business's stock in a transaction dated Friday, August 1st. The stock was sold at an average price of $57.09, for a total value of $114,180.00. Following the transaction, the director directly owned 16,618 shares of the company's stock, valued at $948,721.62. This represents a 10.74% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 31,000 shares of company stock worth $1,825,940. 37.40% of the stock is owned by corporate insiders.
Doximity Stock Performance
Shares of DOCS traded down $1.45 during trading hours on Friday, hitting $57.30. 1,489,193 shares of the company were exchanged, compared to its average volume of 2,352,441. The company has a market cap of $10.76 billion, a PE ratio of 57.30, a PEG ratio of 4.10 and a beta of 1.37. The firm's 50 day moving average is $58.26 and its 200-day moving average is $59.74. Doximity, Inc. has a 52 week low of $25.00 and a 52 week high of $85.21.
Doximity (NASDAQ:DOCS - Get Free Report) last released its quarterly earnings results on Thursday, May 15th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.11. Doximity had a return on equity of 21.75% and a net margin of 36.60%. The business's quarterly revenue was up 17.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.25 earnings per share. As a group, equities analysts forecast that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
DOCS has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. cut their target price on Doximity from $63.00 to $60.00 and set a "neutral" rating on the stock in a research report on Tuesday, May 27th. William Blair reaffirmed an "outperform" rating on shares of Doximity in a research report on Friday, May 16th. Needham & Company LLC cut their target price on Doximity from $82.00 to $67.00 and set a "buy" rating on the stock in a research report on Friday, May 16th. The Goldman Sachs Group set a $50.00 price target on Doximity and gave the company a "neutral" rating in a report on Wednesday, May 21st. Finally, Raymond James Financial lowered their price target on Doximity from $83.00 to $65.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. Ten research analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, Doximity presently has a consensus rating of "Moderate Buy" and a consensus target price of $64.89.
Read Our Latest Analysis on DOCS
Doximity Profile
(
Free Report)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Read More

Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.